Insiders Updates A company insider recently sold 11,366 shares of Mineralys Therapeutics Inc [MLYS]. Should You Sale? Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Mineralys Therapeutics
Stock Earnings Investing in Mineralys Therapeutics Inc (MLYS): What You Must Know Mineralys Therapeutics Inc’s filing revealed that its Director Slingsby Brian Taylor acquired Company’s shares for reported $3.5 million on Mar
Insiders Updates Mineralys Therapeutics Inc (MLYS) receives a Buy rating from H.C. Wainwright Mineralys Therapeutics Inc’s filing revealed that its Director Slingsby Brian Taylor acquired Company’s shares for reported $3.5 million on Mar
Insiders Updates Mineralys Therapeutics Inc [MLYS] Records 50-Day SMA of $12.99 The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or